Researchers Call for Scrutiny of Genetic Panel Testing in Cancer Diagnostics
A Yale study suggests that comprehensive gene panel testing requires greater evaluation to determine their true impact on cancer diagnostics.
Read More
Search Results for: genetic testing
AstraZeneca and Pillar Biosciences Partner to Accelerate Access to Liquid Biopsy Testing
Pillar Biosciences and AstraZeneca seek to expand access to NGS-based liquid biopsy tumor profiling to detect genetic cancer variants.
Read More
MicroRNA Evaluation Could Improve Early Alzheimer’s Diagnosis
Blood-based microRNA biomarkers can predict the progression of Alzheimer’s disease, offering a less invasive method for early diagnosis.
Read More
Increased Testing for Heart Disease Indicator Needed
A new review finds that 20% of the global population carries a genetic risk for cardiovascular diseases due to high levels of lipoprotein(a).
Read More
PathAI Adds MET Predict to AISight for NSCLC Assessments
The MET Predict assists in identifying NSCLC tumors with MET exon 14 skipping or MET amplification directly from H&E whole slide images.
Read More